• Structural Heart Disease Council

    Chairs

    Chair: Clifford J. Kavinsky, MD, PhD, FSCAI (May 2016–May 2019)
    Co-Chair: Zahid Amin, MD, FSCAI (May 2016–May 2019)
    Communications Liaison: Chandan Devireddy, MD, FSCAI
    Education Liaison: Mehmet Cilingiroglu, MD, FSCAI
    Quality Liaison: Anita W. Asgar, MD
    WIN Liaison: Molly Szerlip, MD, FSCAI
    Board Liaison: David A. Cox, MD, MSCAI
    Staff Liaison: Dawn Gray (dgray@scai.org)


    » View List of U.S. Based Structural Training Programs


    Mission

    To provide an interactive forum to address unique issues facing the evolution of less-invasive, catheter-based and hybrid surgical techniques for treating congenital and structural heart disease. In particular, relevant issues pertaining to; physician training and credentialing, reimbursement, and the formation of meaningful relationships with industry and other societies will be emphasized in order to foster innovative research, enhance patient access, and achieve optimal patient care and safety. The Structural Heart Disease Council will coordinate activities with the other SCAI standing committees and will be the final common pathway for establishing and promulgating SCAI policies regarding all matters related to Structural Heart Disease.


    Goals

    • Development of policies regarding allocation of limited resources for structural heart disease procedures.
    • Support the development of guidelines for training at the fellowship level and beyond, as well as, minimum standards for continued certification for the performance of structural heart disease interventions.
    • Assist in developing quality assurance tools for multidisciplinary structural heart disease programs.
      • Provide guidance in establishing a multidisciplinary heart team
      • Defining requirements for a valve center of excellence
    • Play a major role in interactions with the Advocacy Committee in negotiating with third-party payers and Medicare, as well as other professional societies, the FDA, CMS and industry garnering fair and adequate reimbursement and coverage to ensure patient access to structural heart disease procedures.
      • Establish plan to ensure reimbursement and patient access to percutaneous mitral valve repair technologies, left atrial appendage closure procedures and PFO closure procedures.
      • Optimizing patient selection, as well as pre and post care of TAVR patients.
      • Creating a position statement addressing patient selection for percutaneous pulmonic valve
      • To work closely with surgical societies to guarantee patients are properly educated regarding newer, transformational, less-invasive treatment options for structural heart disease.
    • Assist the Congenital Heart Disease Council by directing SCAI experts and resources to support achieving their identified goals.
    • Consider partnering with industry to establish regional training courses sponsored by SCAI focusing on advanced structural heart disease procedures.


    Voting Members

    Member Term Start Term End
    Adnan K. Chhatriwalla, MD, FSCAI May 2016 May 2019
    Andrew Michael Goldsweig, MD, FACC, RPVI, FSCAI May 2018 May 2021
    Ankur Kalra, MD, FSCAI December 2017 May 2020
    Atman P. Shah, MD, FSCAI May 2018 May 2021
    Binita Shah, MD, FSCAI May 2018 May 2021
    Carlos E. Ruiz, MD, PhD, MSCAI May 2016 May 2019
    Chad Kliger, MD, FSCAI December 2017 May 2020
    Christian Spies, MD, FSCAI May 2016 May 2019
    Creighton W. Don, MD, PhD, FSCAI December 2017 May 2020
    Divya Ratan Verma, MD, MS December 2017 May 2020
    Donald J. Hagler, MD, FSCAI December 2017 May 2020
    Eric Horlick, MD, FSCAI May 2016 May 2019
    George S. Hanzel, MD, FSCAI December 2017 May 2020
    Hani Jneid, MD, FAHA, FACC, FSCAI May 2018 May 2021
    Hussam Suradi, MD, FSCAI May 2018 May 2021
    Ignacio Inglessis, MD, FSCAI May 2016 May 2019
    James D. Flaherty, MD, MS, FSCAI May 2018 May 2021
    Jared O'Leary May 2018 May 2021
    John Carroll, MD, MSCAI May 2016 May 2019
    John D. Rhodes, MD, FSCAI May 2016 May 2019
    Kalkidan Bishu, MD, MS, FSCAI May 2018 May 2021
    Kishore J. Harjai, MD, FSCAI May 2018 May 2021
    Konstantinos Dean Boudoulas, MD, FSCAI May 2016 May 2019
    Konstantinos Marmagkiolis, MD, FSCAI May 2018 May 2021
    Kreton Mavromatis, MD, FSCAI May 2016 May 2019
    Larry A. Latson, MD, FSCAI May 2016 May 2019
    Larry S. Dean, MD, MSCAI May 2016 May 2019
    Marie-France Poulin, MD, FSCAI May 2018 May 2021
    Nicholas J. Ruggiero, MD, FSCAI December 2017 May 2020
    Nicklaus K. Slocum, MD, FSCAI December 2017 May 2020
    Pradeep K. Yadav, MD May 2018 May 2021
    Prakash Balan, MD, JD, FSCAI December 2017 May 2020
    Pranav Kansara, MBBS, MS December 2017 May 2020
    Rajeev L. Narayan, MD, FSCAI May 2018 May 2021
    Ryan R. Reeves, MD May 2018 May 2021
    Saibal Kar, MD, FSCAI May 2018 May 2021
    Sandeep Krishnan, MD May 2018 May 2021
    Satish Madiraju, MD, FSCAI May 2018 May 2021
    Ted E. Feldman, MD, MSCAI May 2016 May 2019
    Vijay S. Iyer, MD, PhD, FSCAI May 2018 May 2021
    Wah Wah Htun, MD, FSCAI December 2017 May 2020
    Ziyad M. Hijazi, MD, MSCAI May 2016 May 2019
    Zoltan G. Turi, MSCAI May 2016 May 2019